Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05208203

XuanwuH Acute Ischemic Stroke Registry

Acute ischemic stroke registry--Xuanwu Hospital(XSR) is an academic, independent, prospective, single center, observational registry study. Consecutive acute ischemic stroke patients assessed in stroke "green channel" of Xuanwu Hospital(China) will be enrolled in our study. Patients receive regular treatment and data will be collected as part of clinical routine. Baseline clinical and procedural information as well clinical follow-up information during in-hospital stay, and up to 90 days of stroke onset are collected. Data collected include demographics, National Institute of Health Stroke Scale (NIHSS) on admission, pre-treatment ASPECTS, information on timing and success of thrombolysis or thrombectomy, procedural complications, intracranial hemorrhage, and functional outcome.The study aim to investigate the real situation of assessment, diagnosis and treatment of acute ischemic stroke patients in "green channel",and verify the effect of the improvement of "green channel" process in the diagnosis and treatment of patients with acute ischemic stroke.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Xuanwu Hospital

Beijing, Beijing Municipality, 100053, China

Location status: Recruiting

Location contact

qingfeng Ma, MD

CONTACT

[email protected]

+8613601069493

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of acute ischemic stroke or transient ischemic attack(TIA)
  • Age >18 years
  • Ethic approval in process
  • Receiving assessment in stroke "green channel" of Xuanwu Hospital

Exclusion criteria

  • Non-acute ischemic stroke

Treatment and study plan

telephone call d90

Other

telephone call on day 90 to assess the primary outcome (mRs d90)

Primary outcomes

  1. modified ranking scale on day (mRs) day 90

    Time frame: 90 days

    mRs: modified ranking scale; the scale is a commonly used measurement for the degree of disability or dependence in the daily activities of people who have suffered a stroke; scale range 0-6, with 0 - No symptoms. 1 - No significant disability. Able to carry out all usual activities, despite some symptoms. 2 - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3 - Moderate disability. Requires some help, but able to walk unassisted. 4 - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5 - Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6 - Dead.

Secondary outcomes

  1. Stroke Event

    Time frame: 1year

    The patients were monitored whether they recured ischemic stroke event including transient ischemic attack (TIA) or stroke confirmed by neurologist and diffusion-weighted image MRI.

  2. adverse event

    Time frame: 1year

    The patients were monitored whether they appeared symptomatic intracranial hemorrhage,cerebral hernia or other life-threatening events.

Study contacts

Contact information is provided by the study sponsor or research team.

chuming Yan, MBBS

CONTACT

[email protected]

+8618810673782

qingfeng Ma, MD

CONTACT

[email protected]

+8613601069493

Sponsors and collaborators

Lead sponsor

Xuanwu Hospital, Beijing

Other

Registry information

Official study title

Acute Ischemic Stroke "Green Channel" Registry--Xuanwu Hospital

Important dates

Study start
2021
Primary completion
2022
Study completion
2029
First posted
Jan 26, 2022
Registry last updated
Jan 26, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.